Harmonisation of short-term in vitro culture for the expansion of antigen-specific CD8+ T cells with detection by ELISPOT and HLA-multimer staining

[1]  F. Baldanti,et al.  Enumeration and Characterization of Human Memory T Cells by Enzyme-Linked Immunospot Assays , 2013, Clinical & developmental immunology.

[2]  F. Baldanti,et al.  Detection of Epstein–Barr virus‐specific memory CD4+ T cells using a peptide‐based cultured enzyme‐linked immunospot assay , 2013, Immunology.

[3]  S. H. van der Burg,et al.  Serum-free freezing media support high cell quality and excellent ELISPOT assay performance across a wide variety of different assay protocols , 2012, Cancer Immunology, Immunotherapy.

[4]  H. Rammensee,et al.  Promiscuous survivin peptide induces robust CD4+ T‐cell responses in the majority of vaccinated cancer patients , 2012, International journal of cancer.

[5]  D. Dearnaley,et al.  DNA fusion-gene vaccination in patients with prostate cancer induces high-frequency CD8+ T-cell responses and increases PSA doubling time , 2012, Cancer Immunology, Immunotherapy.

[6]  Steven A. Rosenberg,et al.  Adoptive immunotherapy for cancer: harnessing the T cell response , 2012, Nature Reviews Immunology.

[7]  C. Gouttefangeas,et al.  Serum is not required for ex vivo IFN-γ ELISPOT: a collaborative study of different protocols from the European CIMT Immunoguiding Program , 2010, Cancer Immunology, Immunotherapy.

[8]  Tom H. M. Ottenhoff,et al.  Identification of Major Factors Influencing ELISpot-Based Monitoring of Cellular Responses to Antigens from Mycobacterium tuberculosis , 2009, PloS one.

[9]  S. H. van der Burg,et al.  Performance of serum-supplemented and serum-free media in IFNγ Elispot Assays for human T cells , 2009, Cancer Immunology, Immunotherapy.

[10]  Sylvia Janetzki,et al.  "MIATA"-minimal information about T cell assays. , 2009, Immunity.

[11]  P. Klenerman,et al.  The relationship between human effector and memory T cells measured by ex vivo and cultured ELISPOT following recent and distal priming , 2009, Immunology.

[12]  L. Ben-Porat,et al.  Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium , 2009, Cancer Immunology, Immunotherapy.

[13]  Ferdousi Chowdhury,et al.  Fit for purpose? A case study: validation of immunological endpoint assays for the detection of cellular and humoral responses to anti-tumour DNA fusion vaccines , 2009, Cancer Immunology, Immunotherapy.

[14]  P. Kaleebu,et al.  Concordant Proficiency in Measurement of T-Cell Immunity in Human Immunodeficiency Virus Vaccine Clinical Trials by Peripheral Blood Mononuclear Cell and Enzyme-Linked Immunospot Assays in Laboratories from Three Continents , 2008, Clinical and Vaccine Immunology.

[15]  J. Lisziewicz,et al.  HIV-1-Specific T Cell Precursors with High Proliferative Capacity Correlate with Low Viremia and High CD4 Counts in Untreated Individuals1 , 2008, The Journal of Immunology.

[16]  A. Mackensen,et al.  The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays , 2007, Cancer Immunology, Immunotherapy.

[17]  Sylvia Janetzki,et al.  Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI) , 2007, Cancer Immunology, Immunotherapy.

[18]  Guido Ferrari,et al.  Results of an ELISPOT proficiency panel conducted in 11 laboratories participating in international human immunodeficiency virus type 1 vaccine trials. , 2005, AIDS research and human retroviruses.

[19]  M. Plebanski,et al.  Cellular immunity induced by the recombinant Plasmodium falciparum malaria vaccine, RTS,S/AS02, in semi‐immune adults in The Gambia , 2004, Clinical and experimental immunology.

[20]  P. Ott,et al.  Comparison of cytokine ELISpot assay formats for the detection of islet antigen autoreactive T cells. Report of the third immunology of diabetes society T-cell workshop. , 2003, Journal of autoimmunity.

[21]  Rustom Antia,et al.  Lineage relationship and protective immunity of memory CD8 T cell subsets , 2003, Nature Immunology.

[22]  M. Hudgens,et al.  Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity. , 2003, The Journal of infectious diseases.

[23]  H. Thomas,et al.  Evolution of Epitope-Specific Memory CD4+ T Cells After Clearance of Hepatitis C Virus , 2002, The Journal of Immunology.

[24]  A. Eggermont,et al.  Quantitation of antigen-reactive T cells in peripheral blood by IFNgamma-ELISPOT assay and chromium-release assay: a four-centre comparative trial. , 2000, Journal of immunological methods.